Titel

Merkliste
1 Ergebnisse

Neoadjuvant checkpoint inhibitor immunotherapy for resectab..:

Joel Ho ; Jane Mattei ; Michael Tetzlaff...
https://www.frontiersin.org/articles/10.3389/fonc.2022.1001150/full. , 2022

Link: https://doi.org/10.3389/fonc.2022.1001150

RT Journal
T1 <Title>Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:130631cb682140daaa725bf5649ba720&Exemplar=1&LAN=DE
				
A1 Joel Ho
A1 Jane Mattei
A1 Michael Tetzlaff
A1 Michelle D. Williams
A1 Michael A. Davies
A1 Adi Diab
A1 Isabella C. Glitza Oliva
A1 Jennifer McQuade
A1 Sapna P. Patel
A1 Hussein Tawbi
A1 Michael K. Wong
A1 Sarah B. Fisher
A1 Ehab Hanna
A1 Emily Z. Keung
A1 Merrick Ross
A1 Roi Weiser
A1 Shirley Y. Su
A1 Michael Frumovitz
A1 Larissa A. Meyer
A1 Amir Jazaeri
A1 Curtis A. Pettaway
A1 B. Ashleigh Guadagnolo
A1 Andrew J. Bishop
A1 Devarati Mitra
A1 Ahsan Farooqi
A1 Roland Bassett
A1 Silvana Faria
A1 Priyadharsini Nagarajan
A1 Rodabe N. Amaria
PB Frontiers Media S.A.
YR 2022
K1 mucosal melanoma
K1 immunotherapy
K1 melanoma
K1 neoadjuvant
K1 resectable
K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens
K1 RC254-282
JF https://www.frontiersin.org/articles/10.3389/fonc.2022.1001150/full
LK http://dx.doi.org/https://doi.org/10.3389/fonc.2022.1001150
DO https://doi.org/10.3389/fonc.2022.1001150
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)